FDA Drug Application (206894) for EFAVIRENZ EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by CIPLA LTD

Back to FDA Applications sponsored by CIPLA LTD

Application Number206894
Product Number001
FormTABLET;ORAL
Dosage600MG;200MG;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by CIPLA LTD